195 related articles for article (PubMed ID: 30561882)
21. Nanoparticulate platinum(II) anticancer drug: synthesis and characterization of amphiphilic cyclotriphosphazene-platinum(II) conjugates.
Yu JY; Jun YJ; Jang SH; Lee HJ; Sohn YS
J Inorg Biochem; 2007 Nov; 101(11-12):1931-6. PubMed ID: 17709142
[TBL] [Abstract][Full Text] [Related]
22. Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells.
Kabolizadeh P; Engelmann BJ; Pullen N; Stewart JK; Ryan JJ; Farrell NP
J Biol Inorg Chem; 2012 Jan; 17(1):123-32. PubMed ID: 21918844
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
[TBL] [Abstract][Full Text] [Related]
25. Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin.
Barbanente A; Galliani A; Iacobazzi RM; Lasorsa A; Nardella MI; Pennetta A; Margiotta N; Arnesano F
ChemMedChem; 2022 Jan; 17(1):e202100593. PubMed ID: 34727402
[TBL] [Abstract][Full Text] [Related]
26. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
Yu H; Gou S; Wang Z; Chen F; Fang L
Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
[TBL] [Abstract][Full Text] [Related]
27. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
28. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterisation and potent cytotoxicity of unconventional platinum(iv) complexes with modified lipophilicity.
Deo KM; Sakoff J; Gilbert J; Zhang Y; Aldrich Wright JR
Dalton Trans; 2019 Nov; 48(46):17217-17227. PubMed ID: 31729519
[TBL] [Abstract][Full Text] [Related]
30. Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance.
Fang L; Qin X; Zhao J; Gou S
Inorg Chem; 2019 Feb; 58(3):2191-2200. PubMed ID: 30657321
[TBL] [Abstract][Full Text] [Related]
31. Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides.
Zamora A; Gandioso A; Massaguer A; Buenestado S; Calvis C; Hernández JL; Mitjans F; Rodríguez V; Ruiz J; Marchán V
ChemMedChem; 2018 Sep; 13(17):1755-1762. PubMed ID: 29932312
[TBL] [Abstract][Full Text] [Related]
32. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
[TBL] [Abstract][Full Text] [Related]
33. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
[TBL] [Abstract][Full Text] [Related]
34. Effects of novel alkyl pyridine platinum complexes on apoptosis in Ishikawa endometrial cancer cells.
Czarnomysy R; Bielawska A; Muszyńska A; Bielawski K
Med Chem; 2015; 11(6):540-50. PubMed ID: 25659127
[TBL] [Abstract][Full Text] [Related]
35. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies.
Bai X; Ali A; Wang N; Liu Z; Lv Z; Zhang Z; Zhao X; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2022 Jan; 227():113920. PubMed ID: 34742012
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery.
Berger G; Leclercqz H; Derenne A; Gelbcke M; Goormaghtigh E; Nève J; Mathieu V; Dufrasne F
Bioorg Med Chem; 2014 Jul; 22(13):3527-36. PubMed ID: 24818960
[TBL] [Abstract][Full Text] [Related]
38. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer activity of dichloroplatinum(II) complexes of podophyllotoxin.
Liu X; Zhang LL; Xu XH; Hui L; Zhang JB; Chen SW
Bioorg Med Chem Lett; 2013 Jul; 23(13):3780-4. PubMed ID: 23711918
[TBL] [Abstract][Full Text] [Related]
40. Photocytotoxic cancer cell-targeting platinum(ii) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline.
Upadhyay A; Gautam S; Ramu V; Kondaiah P; Chakravarty AR
Dalton Trans; 2019 Dec; 48(47):17556-17565. PubMed ID: 31748772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
